Timothy An-thy Chan
Impact in
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Diego Chowell (11 shared papers)Jonathan J. Havel (8 shared papers)Kenneth W. Kinzler (6 shared papers)Bert Vogelstein (6 shared papers)Luc G. T. Morris (36 shared papers)Jedd D. Wolchok (15 shared papers)Nadeem Riaz (23 shared papers)Sergio A. Quezada (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (33 papers)Clinical Cancer Research (22 papers)Cell (18 papers)Cell Reports (15 papers)Nature Genetics (13 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Timothy An-thy Chan
358 papers receiving 89.1k citations
Timothy An-thy Chan's Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 21.8k
- Cancer Research 7.0k
- Genetics 5.2k
- Pulmonary and Respiratory Medicine 7.9k
- Otorhinolaryngology 1.1k
Countries citing papers authored by Timothy An-thy Chan
This map shows the geographic impact of Timothy An-thy Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy An-thy Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy An-thy Chan more than expected).
Fields of papers citing papers by Timothy An-thy Chan
This network shows the impact of papers produced by Timothy An-thy Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy An-thy Chan. The network helps show where Timothy An-thy Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy An-thy Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 368 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer Hit paper breakdown → | 2015 | 6660 |
| 2 | The Immune Landscape of Cancer Hit paper breakdown → | 2018 | 4385 |
| 3 | Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma Hit paper breakdown → | 2014 | 3669 |
| 4 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types Hit paper breakdown → | 2019 | 3043 |
| 5 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2633 |
| 6 | Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade Hit paper breakdown → | 2016 | 2538 |
| 7 | Integrated Genomic Characterization of Papillary Thyroid Carcinoma Hit paper breakdown → | 2014 | 2459 |
| 8 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2371 |
| 9 | CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy Hit paper breakdown → | 2019 | 2321 |
| 10 | Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic Hit paper breakdown → | 2018 | 2038 |
| 11 | The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy Hit paper breakdown → | 2019 | 1846 |
| 12 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1758 |
| 13 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1748 |
| 14 | Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab Hit paper breakdown → | 2017 | 1733 |
| 15 | IDH mutation impairs histone demethylation and results in a block to cell differentiation Hit paper breakdown → | 2012 | 1654 |
| 16 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1634 |
| 17 | IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype Hit paper breakdown → | 2012 | 1611 |
| 18 | Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Hit paper breakdown → | 2015 | 1575 |
| 19 | An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells Hit paper breakdown → | 2013 | 986 |
| 20 | PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs Hit paper breakdown → | 1999 | 969 |
About Timothy An-thy Chan
Timothy An-thy Chan is a scholar working on Oncology, Genetics, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 368 papers that have together received 90.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (87 papers), Glioma Diagnosis and Treatment (42 papers), Brain Metastases and Treatment (27 papers), Cancer Genomics and Diagnostics (17 papers), Epigenetics and DNA Methylation (13 papers), Renal cell carcinoma treatment (12 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Head and Neck Cancer Studies (6 papers). The work is most often cited by research in Oncology (21.8k citations), Cancer Research (7.0k citations), Genetics (5.2k citations), Pulmonary and Respiratory Medicine (7.9k citations) and Otorhinolaryngology (1.1k citations). Timothy An-thy Chan has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Diego Chowell, Jonathan J. Havel, Kenneth W. Kinzler, Bert Vogelstein, Luc G. T. Morris, Jedd D. Wolchok, Nadeem Riaz, Sergio A. Quezada, Charles Swanton and Şevin Turcan. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, Cell, Cell Reports and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.